The objective of the study was to compare embryo development rates after transfer of oocytes collected 22 or 33 h after hCG injection into recipients inseminated within the uterus or the oviduct. Oocytes were collected at approximately 22 or 33 h after hCG injections and incubated for approximately 16 or 1.5 h, respectively, before transfer. Intrauterine inseminations using 1 × 10 9 progressively motile sperm were done approximately 12 h before and 2 h after transfer. For intraoviductal inseminations (gamete intrafallopian transfer [GIFT]), semen was centrifuged through a Percoll gradient, and 200,000 progressively motile sperm were transferred with oocytes into the oviduct. Time of oocyte collection (22 or 33 h) after hCG injection
Introduction
Oocyte transfer has been used to obtain pregnancies from subfertile mares with various reproductive pathologies and histories of unsuccessful embryo transfers. During oocyte transfer, the oocyte from a donor mare is transferred into the oviduct of a recipient, and the recipient is inseminated. The first successful collection and transfer of an equine oocyte was accomplished by McKinnon et al. (1988) . However, high success rates for oocyte transfer were not demonstrated until Carnevale and Ginther (1995) obtained embryo development rates of 92% after transfer of oocytes from young donors into young recipients. Although oocyte transfer has proven to be a successful technique for obtaining pregnancies 1 Studies were funded through benefactors of PEG-Preservation of Equine Genetics Program and the Lucy Whittier Foundation. The authors thank James K. Graham and Jason E. Bruemmer for scientific input and Charles F. Scoggin, Celina M. Checura, and Kimberly A. Preis for technical assistance. 
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did not affect embryo development rates (17/25, 68%, vs 12/23, 52%, respectively; P = 0.40). When results from oocyte collections at 22 and 33 h after hCG were combined, oocyte transfer with intraoviductal vs intrauterine insemination resulted in similar (P = 0.70) embryo development rates (12/22, 55%, and 17/26, 65%, respectively). However, the interaction between time of oocyte collection and site of insemination tended to be significant (P = 0.09), suggesting that GIFT using oocytes collected at 33 h after hCG may not be as effective as using oocytes collected at 22 h after hCG. Because intraoviductal insemination requires a low number of sperm, GIFT could be used in cases of male subfertility, frozen semen, or sexed sperm.
from subfertile mares, the procedure requires semen from fertile stallions; in contrast, gamete intrafallopian transfer (GIFT) could potentially be used for stallions with low sperm numbers. During GIFT, oocytes and sperm are transferred into the oviduct. Lower numbers of sperm are required for intraoviductal vs intrauterine inseminations (Carnevale et al., 2000) . In humans, GIFT has been used extensively for subfertile couples, including cases of male subfertility (Asch et al., 1984) . The first successful GIFT in a mare involved transfer of an oocyte and 500,000 sperm into the oviduct of a mare (Carnevale et al., 1999) . Because a low number of sperm is used and sperm are placed near the site of fertilization, GIFT is a potentially valuable technique for producing pregnancies from subfertile stallions, frozen semen, and sexed sperm.
The study was designed to investigate the hypothesis that intrauterine and intraoviductal inseminations for oocyte transfer would result in similar embryo development rates. Objectives were to compare embryo development rates after 1) transfer of oocytes collected 22 or 33 h after hCG administration and 2) the insemination of recipients within the uterus or oviduct.
Materials and Methods
The experiment was conducted in June, July, and August. Light-horse mares (n = 56) between 3 and 15 yr (mean ± SD of 7.0 ± 2.7 yr) were used as oocyte donors and recipients. Oocytes were randomly transferred in the two following groups: the transfer of oocytes into the oviduct with intrauterine insemination using fresh semen and the transfer of oocytes and fresh semen into the oviduct.
Oocyte Collection and Culture
The reproductive tracts of mares were examined by transrectal palpation and ultrasonography. Examinations were done daily during estrus until the following criteria were met: follicle ≥35 mm in diameter, relaxed uterine and cervical tone, and uterine edema. At this time, hCG (human chorionic gonadotropin; 2,500 IU, i.v.; Steris Laboratories Inc., Phoenix, AZ) was administered to donors and recipients to stimulate follicular and oocyte maturation.
Oocytes were collected via transvaginal, ultrasoundguided follicular aspirations (Carnevale and Ginther, 1993 ) using a linear ultrasound transducer (Aloka Co. Ltd., Wallingford, CT) and a 12-gauge double-lumen collection needle (Cook Veterinary Products, Spencer, IN). Oocyte collections were performed 20 to 24 h (21.5 ± 0.8 h; 22-h group) or 32 to 35 h (33.0 ± 0.6 h; 33-h group) after hCG administration. Before aspirations, mares were sedated (xylazine HCl; 0.4 mg/kg, i.v.; Vedco, Inc., St. Joseph, MO and butorphanol tartrate; 0.01 mg/kg, i.v.; Fort Dodge Animal Health, Fort Dodge, IA). Propantheline bromide (0.05 mg/kg, i.v.; Sigma Chemical Co., Saint Louis, MO) was administered to relax rectal tone. The ultrasound transducer was placed in a plastic casing that contained a needle guide (Aloka Co., Ltd.) and inserted into the anterior vagina. The ovary was positioned per rectum to image the preovulatory follicle. The aspiration needle was advanced through the walls of the vagina and preovulatory follicle. Contents of the follicle were gently aspirated (150 mm Hg) using a pump (Cook Veterinary Products) while the follicle was flushed with 100 mL of flush medium (EmCare complete embryo flush solution; ICP, Auckland, New Zealand) supplemented with 10 IU/mL of heparin (Calbiochem; La Jolla, CA) at 38.5°C. Oocytes were immediately identified, washed, and placed in culture medium (TCM-199; Bio Whittaker; Walkersville, MD) with 10% FCS, 0.2 mM pyruvate, and 25 g/mL gentamicin sulfate. Oocytes, collected at 22 or 33 h, were incubated in an atmosphere of 6% CO 2 in air at 38.5°C for 15 to 18 h (16.3 ± 0.6 h) or 1 to 3 h (1.6 ± 0.4 h), respectively. At the completion of culture, oocytes were placed in EmCare holding medium (ICP) for ≤10 min before transfer.
Semen Preparation and Insemination
Three stallions with histories of good fertility were used. For intraoviductal insemination, semen was collected approximately 1 h before GIFT. Raw semen (approximately 150 × 10 6 progressively motile sperm) was centrifuged (10 min at 400 × g) through 4 mL of Percoll gradient (90/45%) in holding medium. The sperm pellet was resuspended and centrifuged for 5 min at 200 × g in 5 mL of holding medium. The sperm pellet was resuspended in holding medium at 40 × 10 6 progressively motile sperm per milliliter. Less than 5 min before transfer, 200,000 progressively motile sperm (5 L) were added to holding medium containing the oocytes (<200 L). Oocytes and sperm were loaded into a firepolished glass pipette and transferred into the recipient's oviduct.
For intrauterine inseminations, 1 × 10 9 progressively motile sperm, extended to 20 mL in a nonfat milk extender containing amikacin (E-Z Mixin "CST"; Animal Reproduction Systems, Chino, CA), were inseminated into the uterine body. Recipients in the 22-h group were inseminated at 13 to 16 h (14.8 ± 1.0) before and at 1 to 2.5 h (1.9 ± 0.4) after oocyte transfer. Recipients in the 33-h group were inseminated at 7 to 11 h (9.2 ± 1.6) before and at 1 to 2 h (1.4 ± 0.2) after oocyte transfer.
Oocyte Transfer
Oviducts of recipients were exposed through standing flank laparotomies, and oocytes were transferred to the side contralateral to that of the recipients' ovulations (Scott et al., 2001) . Multiple oocytes (two or three) were transferred into oviducts of four to five recipients per group.
Recipients were placed in stocks and given a presurgical sedative (xylazine HCl, 0.3 mg/kg, and butorphanol tartrate, 0.01 mg/kg, i.v.). The surgical area was clipped, scrubbed, and blocked with 2% lidocaine. Prior to surgery, mares were given additional sedation (detomidine hydrochloride, 9 g/kg, and butorphanol tartrate, 0.012 mg/kg, i.v.). An incision was made through the skin approximately midway between the last rib and tuber coxae, and the muscle layers were separated by blunt dissection. The ovary and oviduct were exteriorized through the incision. The infundibullar os of the oviduct was located, and oocytes or oocytes and sperm in ≤0.2 mL of holding medium were transferred by advancing a fire-polished glass pipette approximately 2 to 3 cm into the oviductal lumen. Recipients received phenylbutazone (2 g daily) at the time of surgery (i.v.) and for 2 additional days (p.o.). Antibiotics (Penicillin G procaine, 20,000 IU/kg, i.m. daily; Vedco, Inc.) were administered before surgery and for 5 d after transfers.
Uteri of recipients were evaluated by ultrasonography for 2 to 3 d after transfer to detect fluid accumulations. Recipients with uterine fluid accumulation were treated with oxytocin only (20 to 30 IU, i.v.; Troedsson et al., 1995) , or in combination with cloprostenol (Estrumate; 250 g, i.m.; Bayer Corp., Shawnee Mission, KS; Combs et al., 1996) . Mares were treated daily for 1 to 3 d after transfer or until no fluid was observed within the uterus. There were no significant main effects (P > 0.1); the interaction between time of oocyte collection (22 and 33 h) and site of insemination tended to be significant (P = 0.09).
Ultrasound examinations of uteri of recipients were performed on d 12, 14, and 16 after transfer to determine presence and number of embryonic vesicles. On d 16 after transfer, uteri of pregnant recipients were flushed to recover embryonic vesicles. Embryonic vesicles were identified and frozen (−6°C) with a minimal amount of fluid. Embryonic vesicles and the respective recipient's mane fibers were submitted for parentage verification through analysis of microsatellites, using polymerase chain reaction technology (Veterinary Genetics Laboratory, University of California, Davis).
Statistical Analysis
Logistic regression analysis (McCullagh and Nelder, 1989) was performed using the Proc Genmod procedure of SAS (SAS Inst. Inc., Cary, NC). The binomial response was embryo development rates (embryos per transferred oocyte), and independent variables were time of oocyte collection (22 or 33 h), site of insemination (uterine or oviductal), and their interaction. Adjustment for random recipient effects was made by deviance scaling for overdispersion. The experimental unit was considered to be the group of oocytes/embryos in each mare, not the individual oocytes/embryos. Oocyte recovery rates at 22 and 33 h after hCG administration were compared by chi-squared analysis. Effects of treatments used for uterine fluid accumulation on embryo development rates were compared by Fisher's exact test.
Results
Oocytes were recovered in 78% (50/64) of collection attempts. Oocyte recovery rates were similar (P = 0.5) for collections performed at 22 or 33 h after administration of hCG to donors (27/36, 75%, and 23/28, 82%, respectively). Two of the recovered oocytes were not used in the present study because of the asynchrony of recipients.
The interaction of site of insemination by time of oocyte collection tended to be different (P = 0.09). Oocyte transfer with intrauterine insemination resulted in embryo development rates similar (P = 0.7) to those of oocyte transfer with oviductal inseminations (17/26, 65%, and 12/22, 55%, respectively; Table 1 ). Time of oocyte collection (22 or 33 h) after hCG injection did not affect embryo development rates (17/25, 68%, vs 12/ 23, 52%, respectively; P = 0.40).
Pregnancies were obtained in 15 of 17 recipients. All recipients inseminated within the uterus had at least one embryonic vesicle imaged by ultrasound, and only one recipient had only her oocyte fertilized. Two recipients that were inseminated within the oviduct were not pregnant. All oocytes were transferred into the oviduct contralateral to recipients' ovulations. Results from DNA tests for parentage verification demonstrated that 7/9 recipients inseminated within the uterus had their own oocyte fertilized; however, fertilization of recipients' oocytes did not occur when oocytes and sperm were transferred into the oviduct (GIFT).
Uterine fluid accumulations after transfers were observed in 7/9 (78%) of the recipients inseminated within the uterus. Embryo development rates were not significantly different (P = 0.2) between recipients not treated (2/5, 40%), treated with oxytocin only (10/12, 83%), and treated with oxytocin plus cloprostenol (5/ 9, 56%). Recipients that were inseminated within the oviduct (GIFT) did not accumulate fluid in the uterus.
Discussion
Oocytes were collected at two intervals (22 and 33 h) after hCG injection and, presumably, were in different stages of maturation. Oocytes collected 22 to 24 h after hCG injection are predominantly in metaphase I and require culture to complete maturation (Carnevale and Ginther, 1995) . Bezard et al. (1995) observed that 87% of oocytes achieved nuclear maturation 35 h after administration of gonadotropin for induction of ovulation, but, based on the localization of cortical granules in the ooplasm, cytoplasmic maturation was not complete. Oocytes from superstimulated or unstimulated mares were in metaphase II, with cortical granules located in an internal position in 14% and 7% of oocytes, respectively. The findings indicated that cytoplasmic maturation occurred after nuclear maturation in equine oocytes. In the present study, oocyte maturation was estimated by cumulus expansion; nuclear and cytoplasmic maturation were not determined. However, expansion of the granulosa and cumulus cells suggested that follicles responded to hCG and were preparing for ovulation, consistent with the resumption of meiosis (Hinrichs et al., 1998) .
Time of oocyte collection after hCG administration did not affect the oocyte recovery rate. Oocyte recovery rates were similar to rates achieved in previous studies in which the same collection technique was used (65 to 83%; Carnevale and Ginther, 1993; Ray et al., 1994; Carnevale et al., 2000) .
Time of oocyte collection after hCG administration was not a major determinant of success of oocyte transfer when recipients were inseminated within the uterus. Similar results were obtained in a study by Hinrichs et al. (2000) when oocytes were transferred after collection at 24 or 35 h after hCG and cultured for 12 or 1 h, respectively, into recipients inseminated within the uterus (5/8, 63%, for 24 h; 4/9, 44%, for 35 h). In the present experiment, however, when recipients were inseminated within the oviduct, transfer of oocytes collected 22 vs 33 h after hCG injections tended to result in higher embryo development rates (9/11, 88%, vs 3/11, 27%, respectively). Because the number of recipients per group was relatively low, differences in the quality of recipients could have affected results.
Recipients were inseminated within the uterus approximately 12 h before and 2 h after transfers providing two populations of sperm within the oviduct. Sperm inseminated 12 h before transfer were in the oviduct at the time of transfer. Sperm inseminated 2 h after transfer would reach the oviduct in sufficient numbers for fertilization within 4 h of insemination (Troedsson et al., 1998) or 6 h of transfer. Therefore, if additional time was required for oocytes to complete maturation within the oviduct, sperm from the first or second inseminate would be capable of fertilizing the oocyte. During GIFT, semen was deposited in the infundibullar or ampullar region of the oviduct. Because equine sperm bind in greater numbers to oviductal epithelial cells of isthmic than of ampullar origin (Thomas et al., 1994a) , the site of deposition could have contributed to a lower interaction between sperm and oviductal epithelial cells. As a result, when sperm were deposited within the oviduct, selection of normal sperm by the reproductive tract of the recipient may not have occurred, and the lifespan of sperm could have been shortened. Therefore, adequate sperm preparation for intraoviductal insemination may be essential for the success of GIFT.
Before intraoviductal insemination, semen was centrifuged through Percoll to separate sperm from seminal plasma. Centrifugation of semen through Percoll gradient could have initiated the process of capacitation (Arns and Shepherd, 1994) . Changes associated with capacitation resulted in reduced sperm lifespan (Hunter, 1987) and a reduced ability to bind to oviductal epithelial cells (Smith and Yanagimachi, 1989; Lefebvre and Suarez, 1996; Thomas et al., 1995) . Attachment of equine sperm to oviductal epithelial cells resulted in selection of a population of morphologically normal, motile sperm from the inseminate (Thomas et al., 1994b) and an increased lifespan of sperm (Ellington et al., 1993a,b) . Centrifugation of semen through Percoll gradient increased the percentage of motile sperm but may have reduced the longevity of sperm in the oviduct. However, centrifugation of sperm through Percoll gradient did not decrease the fertilizing ability of sperm because pregnancy rates for intrauterine and intraoviductal inseminations were similar.
Uterine fluid accumulations were not observed in recipients inseminated within the oviduct. However, small amounts of clear fluid were observed after transfers in most recipients inseminated within the uterus. All recipients had at least one embryonic vesicle on d 16, suggesting that uterine fluid accumulation for ≤3 d after transfer did not have a deleterious effect on the uterine environment. Hinrichs et al. (2000) observed that 14 of 17 recipients (82%) that were inseminated once the day before transfer and immediately after transfer had fluid within the uterine lumen, and recipients were treated with oxytocin. Pregnancy rates were significantly lower for mares that retained fluid for longer than 2 d after transfer. In the present experiment, administration of cloprostenol in the postovulatory period could have had a detrimental effect on subsequent luteal function or embryo development (Troedsson et al., 2001 ). However, there was no difference in embryo development rates between recipients not treated, treated with oxytocin only, or oxytocin plus cloprostenol. Further research is needed to investigate how the time of insemination affects postbreeding endometritis, uterine fluid accumulations, and pregnancy rates.
During intraoviductal insemination, low numbers of sperm were deposited in the oviduct contralateral to the recipient's ovulation. Parentage tests confirmed that no embryonic vesicles collected from recipients inseminated within the oviduct were from the recipients' own oocytes. Apparently, sperm were not capable of migrating from one oviduct to the opposite oviduct. Therefore, cyclic recipients can be used for GIFT without aspirating the recipient's preovulatory follicle. Exogenous administration of progesterone or progestin would not be necessary because normal concentrations of progesterone would be produced by the recipient's corpus luteum.
In conclusion, pregnancy rates obtained in this experiment after intraoviductal insemination (GIFT) were similar to those obtained with oocyte transfer with intrauterine insemination, regardless of the time of oocyte collection (22 or 33 h). Sperm precapacitation was not required before intraoviductal insemination; therefore, capacitation occurred within the oviduct. Completion of oocyte maturation in vitro had no effect on the fertilizing ability of the oocytes, regardless of the type of insemination.
Implications
Intraoviductal insemination with low numbers of sperm results in fertilization and embryo development. Therefore, this procedure has the potential to be used when sperm numbers are limited. Further studies will focus on using intraoviductal insemination (gamete in-
